Filed under: Convergys Corp (CVG), News Corp’B’ (NWS), Analyst initiations

MOST NOTEWORTHY: GlaxoSmithKline, Equinix and Convergys were today’s noteworthy initiations:

• Societe Generale believes consensus estimates are underestimating the quality of GlaxoSmithKline’s (NYSE: GSK) base commerce. The firm started shares with a Buy rating.
• Merriman believes Equinix’s (NASDAQ: EQIX) details center footprint leaves it highly exposed to changing market dynamics, including virtualization, and initiated shares with a Neutral rating. They see limited upside by the next 12 months.
• Convergys (NYSE: CVG) was reinstated with a Hold rating and $19 target at Kaufman Bros, as they are not confident
  in the company’s 2008 new signings outlook and is concerned that the current restructuring and headcount cuts will prove disruptive by the medium term.

OTHER INITIATIONS:

• First Solar (NASDAQ: FSLR) was initiated with a Buy rating and $360 target at UBS.
• Wachovia resumed coverage of News Corp (NYSE: NWS) with a Market Perform rating.
• Baird initiated Sealed Air (NYSE: SEE) with a Neutral rating.

Permalink | Email this | Comments

Original post by Eric Buscemi

college child support insurance credit card auto insurance law credit repair debt consolidation finance foreclosure